QLM1016

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLM1016, covering 2025-01-29 to 2025-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Study on the Efficacy and Safety of QLM1016 in Schizophrenia [Phase 3]